Research Streams

P2

The ACRI medical technologies research team, recipients of an NBIF Research Chair, is investigating the use of microwaves as an energy source for the detection and treatment of cancer. This research subject is a core disruptive technology that will lead to the development of new, non-invasive treatments and more precise screening methods in the detection of cancer. Specifially, the team is investigating properties of diseased tissues to guide them in the selection of conditions that will lead to improved ablation efficiencies. The team is confident that this research will lead to the improvement of microwave ablation technologies by allowing unparalleled control on the shape and penetration of the microwaves used to ablate diseased tissues, thereby leading to less collateral damage to healthy tissues, while reducing recovery time for the patient.


  • Jocelyn Paré, Ph. D., MSM - Research Scientist
  • Jaqueline Bélanger, Ph. D. - Research Scientist
  • Alexandre Arseneau, MSc. Candidate - Engineering
  • Marc-André Richard, MSc. Candidate - Engineering

Twitter

Archived Articles

btn campain EN
Atlantic Cancer Research Institute 
Pavillon Hôtel-Dieu
35, Providence Street
Moncton, NB E1C 8X3 Canada

info@canceratl.ca
Tel.: 506-862-7512
Fax.: 506-862-7571

Annual Report 2017 Cover
Our annual report
Download PDF bullet blanc

The Atlantic Cancer Research Institute

 (ACRI) is a non-profit organization founded in late 1998 and housed at the Dr. Georges-L.-Dumont University Hospital Centre in Moncton. Thanks to its unique expertise, ACRI has become a true centre of excellence in cancer research.

Our Partners

logo excipio logo chudumont logo soricimedlogo neplogo ccslogo umonctonlogo unblogo vitalitelogo conceptiaCRS logoNBHRF logoMerck Logo.svg